CI Investments Inc
WST icon

CI Investments Inc’s West Pharmaceutical WST Stock Holding History

CI Investments Inc’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$419K Buy
+1,168
New +$357K ﹤0.01% 662
2026
Q1 		– Sell
-827
Closed -$228K – 678
2025
Q4 		$228K Sell
827
-462
-36% -$126K ﹤0.01% 610
2025
Q3 		$338K Sell
1,289
-463
-26% -$113K ﹤0.01% 587
2025
Q2 		$383K Sell
1,752
-57
-3% -$12.2K ﹤0.01% 577
2025
Q1 		$405K Sell
1,809
-12,463
-87% -$3.43M ﹤0.01% 569
2024
Q4 		$4.67M Buy
14,272
+12,090
+554% +$3.8M 0.02% 308
2024
Q3 		$655K Sell
2,182
-110
-5% -$33.7K ﹤0.01% 454
2024
Q2 		$755K Sell
2,292
-158
-6% -$55.8K ﹤0.01% 422
2024
Q1 		$969K Buy
2,450
+497
+25% +$184K ﹤0.01% 392
2023
Q4 		$688K Sell
1,953
-540
-22% -$191K ﹤0.01% 401
2023
Q3 		$935K Buy
2,493
+618
+33% +$239K 0.01% 367
2023
Q2 		$717K Buy
1,875
+806
+75% +$288K ﹤0.01% 400
2023
Q1 		$370K Buy
1,069
+517
+94% +$151K ﹤0.01% 489
2022
Q4 		$130K Buy
552
+157
+40% +$37.2K ﹤0.01% 689
2022
Q3 		$97K Sell
395
-26
-6% -$7.92K ﹤0.01% 709
2022
Q2 		$127K Sell
421
-84
-17% -$27.3K ﹤0.01% 680
2022
Q1 		$207K Sell
505
-255
-34% -$99.8K ﹤0.01% 696
2021
Q4 		$356K Sell
760
-69
-8% -$29.7K ﹤0.01% 659
2021
Q3 		$352K Buy
829
+320
+63% +$135K ﹤0.01% 659
2021
Q2 		$183K Buy
509
+66
+15% +$21.8K ﹤0.01% 754
2021
Q1 		$125K Sell
443
-113
-20% -$32.3K ﹤0.01% 728
2020
Q4 		$158K Sell
556
-804
-59% -$226K ﹤0.01% 684
2020
Q3 		$374K Buy
+1,360
New +$360K ﹤0.01% 462
2019
Q4 		– Sell
-3,549
Closed -$503K – 643
2019
Q3 		$503K Buy
+3,549
New +$489K ﹤0.01% 486

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

CI Investments Inc's WST Position: Q2 2026 in Review

CI Investments Inc opened a new position in West Pharmaceutical (WST) in Q2 2026: 1,168 shares worth $419K. The stake represents ﹤0.01% of the portfolio and ranks #662 among its holdings. This is a return to the name: CI Investments Inc previously reported a position in WST as recently as Q4 2025.

CI Investments Inc first reported a position in WST in Q3 2019 and has held it in 24 quarters since. The position peaked at $4.67M in Q4 2024. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • CI Investments Inc held 1,168 shares of West Pharmaceutical worth $419K as of Q2 2026.
  • West Pharmaceutical was a new CI Investments Inc position in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of CI Investments Inc's portfolio in Q2 2026, its #662 holding.
  • CI Investments Inc first reported a position in West Pharmaceutical in Q3 2019 and has held it in 24 quarters since.
  • CI Investments Inc's West Pharmaceutical position peaked at $4.67M in Q4 2024.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on CI Investments Inc's 13F filing for Q2 2026, filed 13 Aug 2026.